Implementing a person-centered medication review process at hospital: Recommendations based on a scoping review of barriers and facilitators

C. Wawrzyniak, R. Marcilly, L. Douze, S. Pelayo
{"title":"Implementing a person-centered medication review process at hospital: Recommendations based on a scoping review of barriers and facilitators","authors":"C. Wawrzyniak, R. Marcilly, L. Douze, S. Pelayo","doi":"10.5750/EJPCH.V7I4.1776","DOIUrl":null,"url":null,"abstract":"Aim: To provide a person-centered set of recommendations that will help (i) healthcare professionals to implement the medication review process at hospital and (ii) tactical stakeholders to promote medication reviews as standard practice in clinical pharmacy. Background: Although the medication review process is highly relevant for the safety of individual patients and for economic purposes, it appears to be complex to implement and then maintain over time in hospital settings. The stakeholders who implement the medication review process may feel disempowered and often request guidance on how to overcome these problems. Method: We first drew up the most comprehensive possible list of barriers and facilitators (i.e., factors that respectively hinder or help the medication review process at hospitals) by searching the PubMed, Web of Science, and Science Direct databases for case studies describing the implementation of medication reconciliation and medication review processes in hospital settings. Text extracts mentioning facilitators and barriers were divided into thematic units, analysed and classified hierarchically. Based on this list of influencing factors, we developed a series of person-centered recommendations. Results: The analysis of 38 publications led to the identification of 617 factors (346 facilitators and 271 barriers) divided into 9 categories and 67 subcategories. Next, we developed a set of 71 specific recommendations for operational stakeholders on designing, implementing and performing the MRev process at hospital. The recommendations are divided into 6 main categories: Designing the process , Participants , Training , Tools , Information and Organization . We also elaborated a set of 20 key recommendations for local and national decision-makers on sustaining the implementation of the MRev process at hospital. Conclusion: We identified a large number of factors that may impact the implementation of the MRev process at hospital and which therefore have the potential to impact upon person-centeredness. Based on this list, we provide a set of recommendations for operational and tactical stakeholders on supporting the local implementation and nationwide expansion of the MRev process.","PeriodicalId":72966,"journal":{"name":"European journal for person centered healthcare","volume":"210 1","pages":"547-575"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal for person centered healthcare","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5750/EJPCH.V7I4.1776","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Aim: To provide a person-centered set of recommendations that will help (i) healthcare professionals to implement the medication review process at hospital and (ii) tactical stakeholders to promote medication reviews as standard practice in clinical pharmacy. Background: Although the medication review process is highly relevant for the safety of individual patients and for economic purposes, it appears to be complex to implement and then maintain over time in hospital settings. The stakeholders who implement the medication review process may feel disempowered and often request guidance on how to overcome these problems. Method: We first drew up the most comprehensive possible list of barriers and facilitators (i.e., factors that respectively hinder or help the medication review process at hospitals) by searching the PubMed, Web of Science, and Science Direct databases for case studies describing the implementation of medication reconciliation and medication review processes in hospital settings. Text extracts mentioning facilitators and barriers were divided into thematic units, analysed and classified hierarchically. Based on this list of influencing factors, we developed a series of person-centered recommendations. Results: The analysis of 38 publications led to the identification of 617 factors (346 facilitators and 271 barriers) divided into 9 categories and 67 subcategories. Next, we developed a set of 71 specific recommendations for operational stakeholders on designing, implementing and performing the MRev process at hospital. The recommendations are divided into 6 main categories: Designing the process , Participants , Training , Tools , Information and Organization . We also elaborated a set of 20 key recommendations for local and national decision-makers on sustaining the implementation of the MRev process at hospital. Conclusion: We identified a large number of factors that may impact the implementation of the MRev process at hospital and which therefore have the potential to impact upon person-centeredness. Based on this list, we provide a set of recommendations for operational and tactical stakeholders on supporting the local implementation and nationwide expansion of the MRev process.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在医院实施以人为中心的药物审查过程:基于障碍和促进因素范围审查的建议
目的:提供一套以人为本的建议,以帮助(i)医疗保健专业人员在医院实施药物审查过程,(ii)战术利益相关者促进药物审查作为临床药学的标准实践。背景:尽管药物审查过程与个体患者的安全性和经济目的高度相关,但在医院环境中实施和维持这一过程似乎很复杂。实施药物审查过程的利益相关者可能会感到被剥夺了权力,并经常要求指导如何克服这些问题。方法:我们首先通过检索PubMed、Web of Science和Science Direct数据库中描述在医院环境中实施药物和解和药物审查过程的案例研究,列出了最全面的障碍和促进因素(即分别阻碍或帮助医院药物审查过程的因素)。将提及促进因素和障碍因素的文本摘录分成专题单元,分层次进行分析和分类。基于这些影响因素,我们提出了一系列以人为本的建议。结果:通过对38篇文献的分析,共识别出617个影响因素,其中促进因素346个,阻碍因素271个,分为9大类67亚类。接下来,我们为运营利益相关者在医院设计、实施和执行MRev流程制定了一套71条具体建议。这些建议分为6个主要类别:设计过程、参与者、培训、工具、信息和组织。我们还为地方和国家决策者制定了一套20项关于在医院持续实施MRev进程的关键建议。结论:我们确定了大量可能影响医院实施MRev流程的因素,因此这些因素可能会影响以人为本。基于这份清单,我们为业务和战术利益相关者提供了一套建议,以支持MRev进程在当地的实施和在全国范围内的扩展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The ethical and epistemic roles of narrative in person-centred healthcare Person-Centred Healthcare versus Patient Centricity - what is the difference and how are pharmaceutical companies aiming to secure internal representation of the patient voice? Moving past phronesis: clinical reasoning in person-centered care Persons over models: shared decision-making for person-centered medicine lifestyle and degeneracy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1